Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v2-FR
Language French French
Date Updated 2022-09-30 2022-07-25
Drug Identification Number 02132591 02132591
Brand name TEVA-LOPERAMIDE TEVA-LOPERAMIDE
Common or Proper name TEVA-LOPERAMIDE 2MG TABLETS TEVA-LOPERAMIDE 2MG TABLETS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients LOPERAMIDE HYDROCHLORIDE LOPERAMIDE HYDROCHLORIDE
Strength(s) 2MG 2MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100, 12 100, 12
ATC code A07DA A07DA
ATC description ANTIPROPULSIVES ANTIPROPULSIVES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-07-25 2022-07-25
Estimated end date 2022-10-10 2022-08-31
Actual end date 2022-09-30
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments